3-Jul-2025 5:10 AM CST - Seeking Alpha Incyte: New CEO Brings A New Possible Outcome Incyte's new CEO, Bill Meury, signals a potential strategic pivot toward M&A, leveraging his biopharma acquisition experience. Find out why INCY stock is a Buy.
2-Jul-2025 3:30 PM CST - Yahoo Finance Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Incyte Corporation (Nasdaq: INCY) announced today equity inducement awards grants to Bill Meury in connection with his appointment as the Company's new President and Chief Executive Officer. The awards are made pursuant to the Company's 2024 Inducement Stock Incentive Plan and were approved by the compensation committee of the Company's Board of Directors as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
1-Jul-2025 8:33 AM CST - Yahoo Finance Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry's decline of 1.3%. The stock has also outperformed the sector in the said timeframe.
24-Jun-2025 2:05 AM CST - Yahoo Finance How Is Incyte's Stock Performance Compared to Other Biotech Stocks? Incyte has underperformed relative to its biotech peers over the past year, though Wall Street analysts maintain a cautiously optimistic view on the stock's outlook.
22-Jun-2025 11:19 PM CST - Yahoo Finance 5 Revealing Analyst Questions From Incyte's Q1 Earnings Call Incyte's first quarter was marked by significant commercial momentum and robust top-line growth, leading to a positive market reaction. Management attributed the results to strong demand for Jakafi and Opselura,
3-Jul-2025 5:10 AM CST - Seeking Alpha Incyte: New CEO Brings A New Possible Outcome Incyte's new CEO, Bill Meury, signals a potential strategic pivot toward M&A, leveraging his biopharma acquisition experience. Find out why INCY stock is a Buy.
2-Jul-2025 3:30 PM CST - Yahoo Finance Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Incyte Corporation (Nasdaq: INCY) announced today equity inducement awards grants to Bill Meury in connection with his appointment as the Company's new President and Chief Executive Officer. The awards are made pursuant to the Company's 2024 Inducement Stock Incentive Plan and were approved by the compensation committee of the Company's Board of Directors as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
1-Jul-2025 8:33 AM CST - Yahoo Finance Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry's decline of 1.3%. The stock has also outperformed the sector in the said timeframe.
24-Jun-2025 2:05 AM CST - Yahoo Finance How Is Incyte's Stock Performance Compared to Other Biotech Stocks? Incyte has underperformed relative to its biotech peers over the past year, though Wall Street analysts maintain a cautiously optimistic view on the stock's outlook.
22-Jun-2025 11:19 PM CST - Yahoo Finance 5 Revealing Analyst Questions From Incyte's Q1 Earnings Call Incyte's first quarter was marked by significant commercial momentum and robust top-line growth, leading to a positive market reaction. Management attributed the results to strong demand for Jakafi and Opselura,
